Milestone Pharmaceuticals Announces U.S. Availability of CARDAMYST™ (etripamil) Nasal Spray, the First and Only FDA-Approved Self-Administered Treatment for Adu…

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

Milestone Pharmaceuticals Inc.: Milestone Pharmaceuticals Announces U.S. Availability of CARDAMYST (etripamil) Nasal Spray, the First and Only FDA-Approve…

CARDAMYST is now conveniently available to patients through retail pharmaciesNational sales force hired with promotional ...
AHA/ASA Journals

An Atypical Presentation of an Occlusion Myocardial Infarction Requiring Urgent Revascularization

Integrating the reverse Aslanger pattern with Littmann’s continuity, the patient was diagnosed with a high lateral, high-risk, occlusive myocardial infarction. The patient immediately received dual ...